Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-07-11

FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for furosemide from Chartwell RX, LLC, resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

SUPPL AP for FUROSEMIDE (FUROSEMIDE)